David Matthew Stark

Directeur Juridique

Teva Pharmaceutical Industries Ltd Assertio Holdings, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 1 saleDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (3 ops.)

€676k

Latest filing published 16 Jun 2026 for Assertio Holdings, Inc.. Read the official filing

Filing timeline

BuySale

David Matthew Stark

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

David Matthew Stark: trading record in brief

This profile gathers the share dealings of David Matthew Stark across 2 companies, led by Teva Pharmaceutical Industries Ltd and Assertio Holdings, Inc. Over a trading history stretching from 11 May 2021 to 16 June 2026, the count stands at 12 filings.

Sales make up the whole of the open-market record (3 sales, €676k). Besides market trades, the filings include 2 share grants and 6 option exercises.

The newest entry dates from 16 June 2026: a transaction, in Assertio Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.